P2RY14 (purinergic receptor P2Y14) - Rat Genome Database

P2RY14 (purinergic receptor P2Y14) - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

Gene: P2RY14 (purinergic receptor P2Y14) Homo sapiens

Subscribe to Updates

Symbol:

P2RY14

Name:

purinergic receptor P2Y14

RGD ID:

1347256

HGNC Page

Description:

Predicted to enable G protein-coupled purinergic nucleotide receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Predicted to act upstream of or within hematopoietic stem cell homeostasis. Predicted to be located in plasma membrane.

Type:

protein-coding

RefSeq Status:

Previously known as:

BPR105; G protein coupled receptor for UDP-glucose; G protein-coupled receptor 105; G-protein coupled receptor 105; GPR105; KIAA0001; P2Y purinoceptor 14; P2Y(14) receptor; P2Y14; P2Y14 receptor; purinergic receptor P2Y, G-protein coupled, 14; UDP-glucose receptor

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	3	151,212,117 - 151,278,542 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	3	151,212,117 - 151,278,542 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	3	150,929,905 - 150,996,330 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	3	152,412,595 - 152,478,920 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	3	152,412,604 - 152,478,852	NCBI
Celera	3	149,342,683 - 149,409,005 (-)	NCBI		Celera
Cytogenetic Map	3	q25.1	NCBI
HuRef	3	148,302,942 - 148,369,134 (-)	NCBI		HuRef
CHM1_1	3	150,893,105 - 150,959,426 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	3	153,963,174 - 154,029,607 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
P2RY14	Human	COVID-19		HEP		30296672	mRNA:increased expression:bronchoalveolar lavage (human)	RGD

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
P2RY14	Human	glycogen storage disease XV		IAGP	RGD:151859589	8554872	ClinVar Annotator: match by term: Glycogen storage disease XV	ClinVar	PMID:20357282\|PMID:25272951\|PMID:28492532

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
P2RY14	Human	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332276	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of P2RY14 mRNA	CTD	PMID:36331819
P2RY14	Human	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332276	6480464	1,2-Dimethylhydrazine results in increased expression of P2RY14 mRNA	CTD	PMID:22206623
P2RY14	Human	17beta-estradiol	multiple interactions	EXP		6480464	[Estradiol co-treated with Progesterone] results in increased expression of P2RY14 mRNA; [Progesterone co-treated with Estradiol] more ...	CTD	PMID:17404688\|PMID:20660070
P2RY14	Human	17beta-estradiol	decreases expression	ISO	RGD:1332276	6480464	Estradiol results in decreased expression of P2RY14 mRNA	CTD	PMID:39298647
P2RY14	Human	17beta-estradiol	multiple interactions	ISO	RGD:70912	6480464	[bisphenol A co-treated with Estradiol] results in increased expression of P2RY14 mRNA	CTD	PMID:26496021
P2RY14	Human	17beta-estradiol	multiple interactions	ISO	RGD:1332276	6480464	bazedoxifene inhibits the reaction [Estradiol results in increased expression of P2RY14 mRNA]; Lasofoxifene inhibits the more ...	CTD	PMID:18367319
P2RY14	Human	17beta-estradiol	increases expression	ISO	RGD:1332276	6480464	Estradiol results in increased expression of P2RY14 mRNA	CTD	PMID:18367319
P2RY14	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332276	6480464	Tetrachlorodibenzodioxin affects the expression of P2RY14 mRNA	CTD	PMID:21570461
P2RY14	Human	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1332276	6480464	2,2',4,4',5-brominated diphenyl ether affects the expression of P2RY14 mRNA	CTD	PMID:38648751
P2RY14	Human	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1332276	6480464	tetrabromobisphenol A results in decreased expression of P2RY14 mRNA	CTD	PMID:25172293
P2RY14	Human	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332276	6480464	bisphenol S results in increased expression of P2RY14 mRNA	CTD	PMID:30951980
P2RY14	Human	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1332276	6480464	bisphenol S results in decreased methylation of P2RY14 exon; bisphenol S results in decreased methylation more ...	CTD	PMID:33297965
P2RY14	Human	6-propyl-2-thiouracil	decreases expression	ISO	RGD:70912	6480464	Propylthiouracil results in decreased expression of P2RY14 mRNA	CTD	PMID:24780913
P2RY14	Human	acetamide	increases expression	ISO	RGD:70912	6480464	acetamide results in increased expression of P2RY14 mRNA	CTD	PMID:31881176
P2RY14	Human	aflatoxin B1	increases methylation	EXP		6480464	Aflatoxin B1 results in increased methylation of P2RY14 gene	CTD	PMID:27153756
P2RY14	Human	all-trans-retinoic acid	increases expression	EXP		6480464	Tretinoin results in increased expression of P2RY14 mRNA	CTD	PMID:15498508\|PMID:33167477
P2RY14	Human	all-trans-retinoic acid	increases expression	ISO	RGD:1332276	6480464	Tretinoin results in increased expression of P2RY14 mRNA	CTD	PMID:36189433
P2RY14	Human	all-trans-retinoic acid	multiple interactions	ISO	RGD:1332276	6480464	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of P2RY14 mRNA	CTD	PMID:36189433
P2RY14	Human	ammonium chloride	affects expression	ISO	RGD:70912	6480464	Ammonium Chloride affects the expression of P2RY14 mRNA	CTD	PMID:16483693
P2RY14	Human	bazedoxifene	multiple interactions	ISO	RGD:1332276	6480464	bazedoxifene inhibits the reaction [Estradiol results in increased expression of P2RY14 mRNA]	CTD	PMID:18367319
P2RY14	Human	benzo[a]pyrene	decreases expression	ISO	RGD:1332276	6480464	Benzo(a)pyrene results in decreased expression of P2RY14 mRNA	CTD	PMID:19770486
P2RY14	Human	biochanin A	multiple interactions	ISO	RGD:70912	6480464	Fulvestrant inhibits the reaction [biochanin A results in decreased expression of P2RY14 mRNA]	CTD	PMID:34848279
P2RY14	Human	biochanin A	decreases expression	ISO	RGD:70912	6480464	biochanin A results in decreased expression of P2RY14 mRNA	CTD	PMID:34848279
P2RY14	Human	bisphenol A	multiple interactions	ISO	RGD:70912	6480464	[bisphenol A co-treated with Estradiol] results in increased expression of P2RY14 mRNA	CTD	PMID:26496021
P2RY14	Human	bisphenol A	increases expression	ISO	RGD:70912	6480464	bisphenol A results in increased expression of P2RY14 mRNA	CTD	PMID:30816183\|PMID:32528016
P2RY14	Human	bisphenol A	increases expression	ISO	RGD:1332276	6480464	bisphenol A results in increased expression of P2RY14 mRNA	CTD	PMID:30951980
P2RY14	Human	bisphenol A	decreases expression	ISO	RGD:70912	6480464	bisphenol A results in decreased expression of P2RY14 mRNA	CTD	PMID:25181051
P2RY14	Human	bisphenol F	increases expression	ISO	RGD:1332276	6480464	bisphenol F results in increased expression of P2RY14 mRNA	CTD	PMID:30951980
P2RY14	Human	cadmium atom	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of P2RY14 more ...	CTD	PMID:35301059
P2RY14	Human	cadmium dichloride	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of P2RY14 more ...	CTD	PMID:35301059
P2RY14	Human	carbon nanotube	increases expression	ISO	RGD:1332276	6480464	Nanotubes, Carbon analog results in increased expression of P2RY14 mRNA	CTD	PMID:25554681
P2RY14	Human	choline	multiple interactions	ISO	RGD:1332276	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ...	CTD	PMID:20938992
P2RY14	Human	Dibutyl phosphate	affects expression	EXP		6480464	di-n-butylphosphoric acid affects the expression of P2RY14 mRNA	CTD	PMID:37042841
P2RY14	Human	dibutyl phthalate	decreases expression	ISO	RGD:70912	6480464	Dibutyl Phthalate results in decreased expression of P2RY14 mRNA	CTD	PMID:21266533
P2RY14	Human	diuron	decreases expression	ISO	RGD:70912	6480464	Diuron results in decreased expression of P2RY14 mRNA	CTD	PMID:25152437
P2RY14	Human	doxorubicin	decreases expression	ISO	RGD:1332276	6480464	Doxorubicin results in decreased expression of P2RY14 mRNA	CTD	PMID:28608983
P2RY14	Human	ethanol	multiple interactions	ISO	RGD:1332276	6480464	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of P2RY14 mRNA	CTD	PMID:30517762
P2RY14	Human	flutamide	decreases expression	ISO	RGD:70912	6480464	Flutamide results in decreased expression of P2RY14 mRNA	CTD	PMID:24136188
P2RY14	Human	folic acid	multiple interactions	ISO	RGD:1332276	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ...	CTD	PMID:20938992
P2RY14	Human	folic acid	decreases expression	ISO	RGD:1332276	6480464	Folic Acid results in decreased expression of P2RY14 mRNA	CTD	PMID:25629700
P2RY14	Human	fulvestrant	multiple interactions	ISO	RGD:70912	6480464	Fulvestrant inhibits the reaction [biochanin A results in decreased expression of P2RY14 mRNA]	CTD	PMID:34848279
P2RY14	Human	glafenine	decreases expression	ISO	RGD:70912	6480464	Glafenine results in decreased expression of P2RY14 mRNA	CTD	PMID:24136188
P2RY14	Human	inulin	multiple interactions	ISO	RGD:1332276	6480464	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of P2RY14 mRNA	CTD	PMID:36331819
P2RY14	Human	L-methionine	multiple interactions	ISO	RGD:1332276	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ...	CTD	PMID:20938992
P2RY14	Human	lasofoxifene	multiple interactions	ISO	RGD:1332276	6480464	Lasofoxifene inhibits the reaction [Estradiol results in increased expression of P2RY14 mRNA]	CTD	PMID:18367319
P2RY14	Human	lipopolysaccharide	decreases expression	EXP		6480464	Lipopolysaccharides results in decreased expression of P2RY14 mRNA	CTD	PMID:35811015
P2RY14	Human	lipopolysaccharide	multiple interactions	EXP		6480464	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of P2RY14 mRNA; [S-(1,2-dichlorovinyl)cysteine more ...	CTD	PMID:35811015
P2RY14	Human	mifepristone	increases expression	EXP		6480464	Mifepristone results in increased expression of P2RY14 mRNA	CTD	PMID:17584828
P2RY14	Human	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1332276	6480464	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of P2RY14 mRNA	CTD	PMID:36189433
P2RY14	Human	oxaliplatin	multiple interactions	ISO	RGD:70912	6480464	[oxaliplatin co-treated with Topotecan] results in increased expression of P2RY14 mRNA	CTD	PMID:25729387
P2RY14	Human	ozone	multiple interactions	EXP		6480464	[Air Pollutants results in increased abundance of Ozone] which affects the expression of P2RY14 mRNA	CTD	PMID:35430440
P2RY14	Human	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332276	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of P2RY14 mRNA; [perfluorooctane sulfonic more ...	CTD	PMID:36331819
P2RY14	Human	perfluorooctanoic acid	decreases expression	ISO	RGD:70912	6480464	perfluorooctanoic acid results in decreased expression of P2RY14 mRNA	CTD	PMID:19162173
P2RY14	Human	phenobarbital	affects expression	ISO	RGD:1332276	6480464	Phenobarbital affects the expression of P2RY14 mRNA	CTD	PMID:23091169
P2RY14	Human	pirinixic acid	multiple interactions	ISO	RGD:1332276	6480464	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ...	CTD	PMID:19710929\|PMID:20813756
P2RY14	Human	pirinixic acid	increases expression	ISO	RGD:1332276	6480464	pirinixic acid results in increased expression of P2RY14 mRNA	CTD	PMID:18301758\|PMID:20813756\|PMID:23811191
P2RY14	Human	progesterone	multiple interactions	EXP		6480464	[Estradiol co-treated with Progesterone] results in increased expression of P2RY14 mRNA; [Progesterone co-treated with Estradiol] more ...	CTD	PMID:17404688\|PMID:20660070
P2RY14	Human	progesterone	multiple interactions	ISO	RGD:1332276	6480464	Progesterone inhibits the reaction [Estradiol results in increased expression of P2RY14 mRNA]	CTD	PMID:18367319
P2RY14	Human	progesterone	increases expression	EXP		6480464	Progesterone results in increased expression of P2RY14 mRNA	CTD	PMID:17404688\|PMID:20864642
P2RY14	Human	raloxifene	multiple interactions	ISO	RGD:1332276	6480464	Raloxifene Hydrochloride inhibits the reaction [Estradiol results in increased expression of P2RY14 mRNA]	CTD	PMID:18367319
P2RY14	Human	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		6480464	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of P2RY14 mRNA; [S-(1,2-dichlorovinyl)cysteine more ...	CTD	PMID:35811015
P2RY14	Human	silver atom	increases expression	ISO	RGD:1332276	6480464	Silver results in increased expression of P2RY14 mRNA	CTD	PMID:27131904
P2RY14	Human	silver(0)	increases expression	ISO	RGD:1332276	6480464	Silver results in increased expression of P2RY14 mRNA	CTD	PMID:27131904
P2RY14	Human	Soman	decreases expression	ISO	RGD:70912	6480464	Soman results in decreased expression of P2RY14 mRNA	CTD	PMID:19281266
P2RY14	Human	tamibarotene	increases expression	EXP		6480464	tamibarotene results in increased expression of P2RY14 mRNA	CTD	PMID:15498508
P2RY14	Human	tetrachloromethane	affects expression	ISO	RGD:1332276	6480464	Carbon Tetrachloride affects the expression of P2RY14 mRNA	CTD	PMID:17484886
P2RY14	Human	tetrachloromethane	multiple interactions	ISO	RGD:1332276	6480464	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of P2RY14 mRNA	CTD	PMID:30517762
P2RY14	Human	tetrachloromethane	increases expression	ISO	RGD:1332276	6480464	Carbon Tetrachloride results in increased expression of P2RY14 mRNA	CTD	PMID:27339419
P2RY14	Human	toluene	increases expression	ISO	RGD:70912	6480464	Toluene results in increased expression of P2RY14 mRNA	CTD	PMID:22967744
P2RY14	Human	topotecan	multiple interactions	ISO	RGD:70912	6480464	[oxaliplatin co-treated with Topotecan] results in increased expression of P2RY14 mRNA	CTD	PMID:25729387
P2RY14	Human	triphenyl phosphate	affects expression	EXP		6480464	triphenyl phosphate affects the expression of P2RY14 mRNA	CTD	PMID:37042841
P2RY14	Human	valproic acid	decreases methylation	EXP		6480464	Valproic Acid results in decreased methylation of P2RY14 gene	CTD	PMID:29154799
P2RY14	Human	vinclozolin	increases expression	ISO	RGD:70912	6480464	vinclozolin results in increased expression of P2RY14 mRNA	CTD	PMID:22570695

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
P2RY14	Human	G protein-coupled purinergic nucleotide receptor signaling pathway	involved_in	IEA	GO:0045028	150520179		GOC	GO_REF:0000108
P2RY14	Human	G protein-coupled receptor signaling pathway	involved_in	IEA	UniProtKB-KW:KW-0297	150520179		UniProt	GO_REF:0000043
P2RY14	Human	G protein-coupled receptor signaling pathway	involved_in	IBA	MGI:1918089\|MGI:2442043\|PANTHER:PTN000661229\|RGD:1585271\|RGD:61897\|RGD:621681\|UniProtKB:P25105\|UniProtKB:Q9H244\|ZFIN:ZDB-GENE-030131-7228	150520179		GO_Central	GO_REF:0000033
P2RY14	Human	G protein-coupled receptor signaling pathway	involved_in	NAS		150520179	PMID:10753868	UniProt	PMID:10753868
P2RY14	Human	G protein-coupled receptor signaling pathway	involved_in	IEA	InterPro:IPR000276\|InterPro:IPR005466	150520179		InterPro	GO_REF:0000002
P2RY14	Human	hematopoietic stem cell homeostasis	acts_upstream_of_or_within	IEA	UniProtKB:Q9ESG6\|ensembl:ENSMUSP00000066669	150520179		Ensembl	GO_REF:0000107
P2RY14	Human	immune response		ISO	RGD:70912	9068941		RGD	PMID:9295203\|REF_RGD_ID:70751
P2RY14	Human	signal transduction	involved_in	IEA	UniProtKB-KW:KW-0807	150520179		UniProt	GO_REF:0000043

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
P2RY14	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
P2RY14	Human	membrane	located_in	NAS		150520179	PMID:10753868	UniProt	PMID:10753868
P2RY14	Human	membrane	located_in	IEA	InterPro:IPR000276\|InterPro:IPR005466\|InterPro:IPR017452	150520179		InterPro	GO_REF:0000002
P2RY14	Human	plasma membrane	located_in	TAS		150520179		Reactome	Reactome:R-HSA-380073\|Reactome:R-HSA-417858\|Reactome:R-HSA-749454\|Reactome:R-HSA-749456
P2RY14	Human	plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0039	150520179		UniProt	GO_REF:0000044
P2RY14	Human	plasma membrane	located_in	IEA	UniProtKB-KW:KW-1003	150520179		UniProt	GO_REF:0000043

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
P2RY14	Human	G protein-coupled purinergic nucleotide receptor activity	enables	IEA	InterPro:IPR005466	150520179		InterPro	GO_REF:0000002
P2RY14	Human	G protein-coupled purinergic nucleotide receptor activity	enables	IBA	MGI:1918089\|PANTHER:PTN000661229\|RGD:1302941\|RGD:621681\|UniProtKB:Q9H244	150520179		GO_Central	GO_REF:0000033
P2RY14	Human	G protein-coupled receptor activity	enables	IEA	UniProtKB-KW:KW-0297	150520179		UniProt	GO_REF:0000043
P2RY14	Human	G protein-coupled receptor activity	enables	IEA	InterPro:IPR000276	150520179		InterPro	GO_REF:0000002
P2RY14	Human	G protein-coupled UDP receptor activity	enables	NAS		150520179	PMID:10753868	UniProt	PMID:10753868

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
3.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions
4.	Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.	Zhou Z, etal., Cell Host Microbe. 2020 Jun 10;27(6):883-890.e2. doi: 10.1016/j.chom.2020.04.017. Epub 2020 May 4.

PMID:2834384	PMID:7584026	PMID:7584028	PMID:8011297	PMID:9295203	PMID:10704288	PMID:10753868	PMID:11273702	PMID:11524702	PMID:12369950	PMID:12477932	PMID:12559763
PMID:12695547	PMID:12842911	PMID:12902497	PMID:14559350	PMID:15481977	PMID:15489334	PMID:15829433	PMID:16109883	PMID:16257449	PMID:16263727	PMID:16475938	PMID:16820147
PMID:17016747	PMID:17088057	PMID:18240029	PMID:18577758	PMID:18690346	PMID:19454705	PMID:21873635	PMID:22673622	PMID:23333304	PMID:23592514	PMID:24847057	PMID:25130324
PMID:26186194	PMID:27732965	PMID:28514442	PMID:28804125	PMID:28980705	PMID:33011563	PMID:33575962	PMID:33961781	PMID:35256949	PMID:35385339	PMID:36029226

P2RY14
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	3	151,212,117 - 151,278,542 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	3	151,212,117 - 151,278,542 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	3	150,929,905 - 150,996,330 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	3	152,412,595 - 152,478,920 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	3	152,412,604 - 152,478,852	NCBI
Celera	3	149,342,683 - 149,409,005 (-)	NCBI		Celera
Cytogenetic Map	3	q25.1	NCBI
HuRef	3	148,302,942 - 148,369,134 (-)	NCBI		HuRef
CHM1_1	3	150,893,105 - 150,959,426 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	3	153,963,174 - 154,029,607 (-)	NCBI		T2T-CHM13v2.0

P2ry14
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	3	59,022,044 - 59,060,913 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	3	59,021,276 - 59,061,039 (-)	Ensembl		GRCm39 Ensembl
GRCm38	3	59,114,623 - 59,153,492 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	3	59,113,855 - 59,153,618 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	3	58,918,547 - 58,934,546 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	3	59,202,554 - 59,218,553 (-)	NCBI		MGSCv36	mm8
Celera	3	58,801,934 - 58,817,836 (-)	NCBI		Celera
Cytogenetic Map	3	D	NCBI
cM Map	3	28.96	NCBI

P2ry14
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	2	145,522,598 - 145,563,074 (-)	NCBI		GRCr8
mRatBN7.2	2	143,372,697 - 143,413,213 (-)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	2	143,372,697 - 143,413,141 (-)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	2	150,013,571 - 150,029,564 (-)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	2	148,125,045 - 148,140,995 (-)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	2	142,757,465 - 142,773,415 (-)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	2	149,331,948 - 149,379,336 (-)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	2	149,331,948 - 149,347,796 (-)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	2	168,749,682 - 168,791,344 (-)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	2	148,501,968 - 148,503,616 (-)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	2	148,451,930 - 148,453,579 (-)	NCBI
Celera	2	137,798,540 - 137,800,188 (-)	NCBI		Celera
Cytogenetic Map	2	q26	NCBI

P2ry14
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955448	2,350,846 - 2,367,633 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955448	2,350,846 - 2,367,633 (-)	NCBI	ChiLan1.0	ChiLan1.0

P2RY14
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	2	149,111,794 - 149,177,346 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	3	149,116,527 - 149,182,005 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	3	148,240,705 - 148,306,186 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	3	155,810,973 - 155,876,246 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	3	155,812,156 - 155,813,172 (-)	Ensembl	panpan1.1		panPan2

P2RY14
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	23	45,803,507 - 45,821,981 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	23	45,798,344 - 45,799,366 (-)	Ensembl	CanFam3.1		canFam3	CanFam3.1
CanFam3.1 Ensembl	23	45,798,344 - 45,799,366 (-)	NCBI	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	23	45,662,190 - 45,713,761 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	23	46,424,518 - 46,476,154 (-)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	23	46,425,607 - 46,426,629 (-)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	23	46,013,431 - 46,065,011 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	23	46,065,643 - 46,117,226 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	23	46,342,696 - 46,394,382 (-)	NCBI		UU_Cfam_GSD_1.0

P2ry14
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024405602	90,240,000 - 90,281,060 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936758	1,494,234 - 1,527,789 (-)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936758	1,494,253 - 1,509,217 (-)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

P2RY14
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	13	91,396,675 - 91,453,699 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	13	91,396,006 - 91,453,761 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	13	99,454,991 - 99,459,639 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

P2RY14
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	15	39,419,181 - 39,481,252 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	15	39,480,167 - 39,481,183 (+)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666041	12,238,163 - 12,299,403 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

P2ry14
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624730	28,675,960 - 28,694,708 (-)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624730	28,674,935 - 28,695,749 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

.

Variants in P2RY14
39 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 3q25.1-25.2(chr3:151142354-154931417)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051577]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051577]\|See cases [RCV000051577]	Chr3:151142354..154931417 [GRCh38] Chr3:150860141..154649206 [GRCh37] Chr3:152342831..156131900 [NCBI36] Chr3:3q25.1-25.2	pathogenic
GRCh38/hg38 3q24-26.32(chr3:147442566-178522531)x3	copy number gain	See cases [RCV000051724]	Chr3:147442566..178522531 [GRCh38] Chr3:147160353..178240319 [GRCh37] Chr3:148643043..179723013 [NCBI36] Chr3:3q24-26.32	pathogenic
GRCh38/hg38 3q24-29(chr3:147521892-198096565)x3	copy number gain	See cases [RCV000051725]	Chr3:147521892..198096565 [GRCh38] Chr3:147239679..197823436 [GRCh37] Chr3:148722369..199307833 [NCBI36] Chr3:3q24-29	pathogenic
GRCh38/hg38 3q22.3-29(chr3:137126982-198110178)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051723]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051723]\|See cases [RCV000051723]	Chr3:137126982..198110178 [GRCh38] Chr3:136845824..197837049 [GRCh37] Chr3:138328514..199321446 [NCBI36] Chr3:3q22.3-29	pathogenic
NM_053002.5(MED12L):c.2145+63249T>C	single nucleotide variant	Lung cancer [RCV000093083]	Chr3:151256914 [GRCh38] Chr3:150974702 [GRCh37] Chr3:3q25.1	uncertain significance
GRCh38/hg38 3q13.11-29(chr3:103426882-198110178)x3	copy number gain	See cases [RCV000134948]	Chr3:103426882..198110178 [GRCh38] Chr3:103145726..197837049 [GRCh37] Chr3:104628416..199321446 [NCBI36] Chr3:3q13.11-29	pathogenic
GRCh38/hg38 3q25.1(chr3:151182346-151437002)x3	copy number gain	See cases [RCV000141402]	Chr3:151182346..151437002 [GRCh38] Chr3:150900133..151154790 [GRCh37] Chr3:152382823..152637480 [NCBI36] Chr3:3q25.1	uncertain significance
GRCh37/hg19 3q24-29(chr3:142995020-192997215)x4	copy number gain	See cases [RCV000240256]	Chr3:142995020..192997215 [GRCh37] Chr3:3q24-29	pathogenic
GRCh37/hg19 3q24-25.2(chr3:148425748-153220169)x1	copy number loss	See cases [RCV000447056]	Chr3:148425748..153220169 [GRCh37] Chr3:3q24-25.2	pathogenic
GRCh37/hg19 3q24-26.2(chr3:147180945-168415875)x1	copy number loss	See cases [RCV000448130]	Chr3:147180945..168415875 [GRCh37] Chr3:3q24-26.2	pathogenic
GRCh37/hg19 3q25.1(chr3:150915867-151163492)x3	copy number gain	See cases [RCV000448228]	Chr3:150915867..151163492 [GRCh37] Chr3:3q25.1	uncertain significance
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986)	copy number gain	See cases [RCV000512358]	Chr3:61892..197851986 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3q25.1-25.2(chr3:150352753-153522663)x1	copy number loss	See cases [RCV000510834]	Chr3:150352753..153522663 [GRCh37] Chr3:3q25.1-25.2	likely pathogenic
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986)x3	copy number gain	See cases [RCV000511055]	Chr3:61892..197851986 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3q25.1(chr3:150760009-151097391)x3	copy number gain	not provided [RCV000682316]	Chr3:150760009..151097391 [GRCh37] Chr3:3q25.1	likely benign
GRCh37/hg19 3p26.3-q29(chr3:61495-197838262)x3	copy number gain	not provided [RCV000742138]	Chr3:61495..197838262 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3p26.3-q29(chr3:60174-197948027)x3	copy number gain	not provided [RCV000742133]	Chr3:60174..197948027 [GRCh37] Chr3:3p26.3-q29	pathogenic
NM_014879.4(P2RY14):c.902C>T (p.Pro301Leu)	single nucleotide variant	not provided [RCV000903939]	Chr3:151213415 [GRCh38] Chr3:150931203 [GRCh37] Chr3:3q25.1	benign
GRCh37/hg19 3q25.1-25.2(chr3:149404255-152786331)x1	copy number loss	not provided [RCV001005477]	Chr3:149404255..152786331 [GRCh37] Chr3:3q25.1-25.2	pathogenic
GRCh37/hg19 3q25.1(chr3:150766211-151098711)x3	copy number gain	not provided [RCV000846996]	Chr3:150766211..151098711 [GRCh37] Chr3:3q25.1	uncertain significance
GRCh37/hg19 3q25.1(chr3:150534295-151213925)x3	copy number gain	not provided [RCV001005478]	Chr3:150534295..151213925 [GRCh37] Chr3:3q25.1	uncertain significance
GRCh37/hg19 3q22.3-26.1(chr3:138145289-162275610)x3	copy number gain	See cases [RCV001194586]	Chr3:138145289..162275610 [GRCh37] Chr3:3q22.3-26.1	pathogenic
GRCh37/hg19 3q25.1(chr3:150898716-151133816)x3	copy number gain	not provided [RCV001259242]	Chr3:150898716..151133816 [GRCh37] Chr3:3q25.1	likely benign
GRCh37/hg19 3q25.1(chr3:150898920-151165339)x3	copy number gain	not provided [RCV001259243]	Chr3:150898920..151165339 [GRCh37] Chr3:3q25.1	uncertain significance
GRCh37/hg19 3q25.1(chr3:150922637-151168813)x3	copy number gain	not provided [RCV001259244]	Chr3:150922637..151168813 [GRCh37] Chr3:3q25.1	uncertain significance
GRCh37/hg19 3q22.3-26.1(chr3:138173683-162494699)	copy number gain	Global developmental delay [RCV001352648]	Chr3:138173683..162494699 [GRCh37] Chr3:3q22.3-26.1	pathogenic
GRCh37/hg19 3q24-26.1(chr3:143439359-165252122)x1	copy number loss	not provided [RCV001795847]	Chr3:143439359..165252122 [GRCh37] Chr3:3q24-26.1	pathogenic
GRCh37/hg19 3q23-25.32(chr3:142729607-157921084)x3	copy number gain	Brachycephaly [RCV001801182]	Chr3:142729607..157921084 [GRCh37] Chr3:3q23-25.32	pathogenic
GRCh37/hg19 3q25.1(chr3:150889080-151090963)x1	copy number loss	not provided [RCV001832969]	Chr3:150889080..151090963 [GRCh37] Chr3:3q25.1	uncertain significance
GRCh37/hg19 3q24-25.33(chr3:145486960-160504834)	copy number gain	not specified [RCV002053375]	Chr3:145486960..160504834 [GRCh37] Chr3:3q24-25.33	pathogenic
NC_000003.11:g.(?_148447967)_(151176497_?)del	deletion	Glycogen storage disease XV [RCV003120787]	Chr3:148447967..151176497 [GRCh37] Chr3:3q24-25.1	pathogenic
GRCh37/hg19 3q13.31-26.31(chr3:116620308-172042292)x3	copy number gain	not provided [RCV002472621]	Chr3:116620308..172042292 [GRCh37] Chr3:3q13.31-26.31	pathogenic
NM_014879.4(P2RY14):c.577G>A (p.Ala193Thr)	single nucleotide variant	not specified [RCV004112773]	Chr3:151213740 [GRCh38] Chr3:150931528 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.401C>T (p.Ser134Leu)	single nucleotide variant	not specified [RCV004170475]	Chr3:151213916 [GRCh38] Chr3:150931704 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.431T>C (p.Ile144Thr)	single nucleotide variant	not specified [RCV004069765]	Chr3:151213886 [GRCh38] Chr3:150931674 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.980G>A (p.Arg327Lys)	single nucleotide variant	not specified [RCV004232763]	Chr3:151213337 [GRCh38] Chr3:150931125 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.961G>C (p.Asp321His)	single nucleotide variant	not specified [RCV004167009]	Chr3:151213356 [GRCh38] Chr3:150931144 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.19A>C (p.Thr7Pro)	single nucleotide variant	not specified [RCV004069588]	Chr3:151214298 [GRCh38] Chr3:150932086 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.250C>T (p.Leu84Phe)	single nucleotide variant	not specified [RCV004086003]	Chr3:151214067 [GRCh38] Chr3:150931855 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.838A>T (p.Thr280Ser)	single nucleotide variant	not specified [RCV004318990]	Chr3:151213479 [GRCh38] Chr3:150931267 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.379C>T (p.Leu127Phe)	single nucleotide variant	not specified [RCV004365265]	Chr3:151213938 [GRCh38] Chr3:150931726 [GRCh37] Chr3:3q25.1	uncertain significance
Single allele	duplication	not provided [RCV003448680]	Chr3:140154329..197847235 [GRCh37] Chr3:3q23-29	pathogenic
NM_014879.4(P2RY14):c.486G>C (p.Gln162His)	single nucleotide variant	not specified [RCV004497530]	Chr3:151213831 [GRCh38] Chr3:150931619 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.110T>G (p.Ile37Ser)	single nucleotide variant	not specified [RCV004497529]	Chr3:151214207 [GRCh38] Chr3:150931995 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.500T>C (p.Val167Ala)	single nucleotide variant	not specified [RCV004497531]	Chr3:151213817 [GRCh38] Chr3:150931605 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.534A>C (p.Glu178Asp)	single nucleotide variant	not specified [RCV004497533]	Chr3:151213783 [GRCh38] Chr3:150931571 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.577G>T (p.Ala193Ser)	single nucleotide variant	not specified [RCV004497534]	Chr3:151213740 [GRCh38] Chr3:150931528 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.518T>C (p.Ile173Thr)	single nucleotide variant	not specified [RCV004497532]	Chr3:151213799 [GRCh38] Chr3:150931587 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.749A>G (p.His250Arg)	single nucleotide variant	not specified [RCV004497535]	Chr3:151213568 [GRCh38] Chr3:150931356 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.884A>C (p.Tyr295Ser)	single nucleotide variant	not specified [RCV004497536]	Chr3:151213433 [GRCh38] Chr3:150931221 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.488G>A (p.Ser163Asn)	single nucleotide variant	not specified [RCV004650633]	Chr3:151213829 [GRCh38] Chr3:150931617 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.212G>C (p.Ser71Thr)	single nucleotide variant	not specified [RCV004650634]	Chr3:151214105 [GRCh38] Chr3:150931893 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.315G>C (p.Met105Ile)	single nucleotide variant	not specified [RCV004663958]	Chr3:151214002 [GRCh38] Chr3:150931790 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.285G>T (p.Arg95Ser)	single nucleotide variant	not specified [RCV004650631]	Chr3:151214032 [GRCh38] Chr3:150931820 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.135G>C (p.Trp45Cys)	single nucleotide variant	not specified [RCV004650632]	Chr3:151214182 [GRCh38] Chr3:150931970 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.10T>C (p.Ser4Pro)	single nucleotide variant	not specified [RCV004663959]	Chr3:151214307 [GRCh38] Chr3:150932095 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.541C>T (p.Arg181Trp)	single nucleotide variant	not specified [RCV004663956]	Chr3:151213776 [GRCh38] Chr3:150931564 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.172A>G (p.Ile58Val)	single nucleotide variant	not specified [RCV004663957]	Chr3:151214145 [GRCh38] Chr3:150931933 [GRCh37] Chr3:3q25.1	likely benign
NM_014879.4(P2RY14):c.254G>A (p.Gly85Asp)	single nucleotide variant	not specified [RCV004838901]	Chr3:151214063 [GRCh38] Chr3:150931851 [GRCh37] Chr3:3q25.1	uncertain significance
GRCh37/hg19 3q24-25.1(chr3:146504503-151662391)x1	copy number loss	not provided [RCV004819285]	Chr3:146504503..151662391 [GRCh37] Chr3:3q24-25.1	likely pathogenic
NM_014879.4(P2RY14):c.119A>G (p.Asn40Ser)	single nucleotide variant	not specified [RCV004838899]	Chr3:151214198 [GRCh38] Chr3:150931986 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.56T>C (p.Leu19Pro)	single nucleotide variant	not specified [RCV004838903]	Chr3:151214261 [GRCh38] Chr3:150932049 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.115C>G (p.Leu39Val)	single nucleotide variant	not specified [RCV004838900]	Chr3:151214202 [GRCh38] Chr3:150931990 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.440T>C (p.Met147Thr)	single nucleotide variant	not specified [RCV004838902]	Chr3:151213877 [GRCh38] Chr3:150931665 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.388T>G (p.Ser130Ala)	single nucleotide variant	not specified [RCV004827543]	Chr3:151213929 [GRCh38] Chr3:150931717 [GRCh37] Chr3:3q25.1	uncertain significance
NM_014879.4(P2RY14):c.373A>G (p.Lys125Glu)	single nucleotide variant	not specified [RCV004827544]	Chr3:151213944 [GRCh38] Chr3:150931732 [GRCh37] Chr3:3q25.1	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	571
Count of miRNA genes:	399
Interacting mature miRNAs:	420
Transcripts:	ENST00000309170, ENST00000424796, ENST00000494668
Prediction methods:	Miranda, Rnahybrid
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597018325	GWAS1114399_H	eosinophil count QTL GWAS1114399 (human)		7e-11	eosinophil quantity (VT:0002602)	blood eosinophil count (CMO:0000033)	3	151225751	151225752	Human
597513324	GWAS1609398_H	diverticular disease QTL GWAS1609398 (human)		0.000004	diverticular disease		3	151261685	151261686	Human
597455780	GWAS1551854_H	eosinophil count QTL GWAS1551854 (human)		2e-11	eosinophil quantity (VT:0002602)	blood eosinophil count (CMO:0000033)	3	151225751	151225752	Human
1300026	BP36_H	Blood pressure QTL 36 (human)	4.04		Blood pressure	hypertension susceptibility	3	135720453	161720453	Human
597018700	GWAS1114774_H	eosinophil count QTL GWAS1114774 (human)		1e-09	eosinophil quantity (VT:0002602)	blood eosinophil count (CMO:0000033)	3	151223704	151223705	Human
597365377	GWAS1461451_H	eosinophil count QTL GWAS1461451 (human)		3e-11	eosinophil quantity (VT:0002602)	blood eosinophil count (CMO:0000033)	3	151223704	151223705	Human
1298415	BP24_H	Blood pressure QTL 24 (human)	2.9		Blood pressure	hypertension susceptibility	3	135720453	161720453	Human
597281861	GWAS1377935_H	insomnia QTL GWAS1377935 (human)		3e-08	insomnia		3	151249481	151249482	Human
597018619	GWAS1114693_H	eosinophil count QTL GWAS1114693 (human)		5e-13	eosinophil quantity (VT:0002602)	blood eosinophil count (CMO:0000033)	3	151223704	151223705	Human

D3S3625

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,987,163 - 150,987,344	UniSTS	GRCh37
Build 36	3	152,469,853 - 152,470,034	RGD	NCBI36
Celera	3	149,399,936 - 149,400,117	RGD
Cytogenetic Map	3	q24-q25.1	UniSTS
Cytogenetic Map	3	q25.1	UniSTS
HuRef	3	148,360,077 - 148,360,248	UniSTS
Marshfield Genetic Map	3	168.94	UniSTS
Marshfield Genetic Map	3	168.94	RGD
Genethon Genetic Map	3	173.0	UniSTS
deCODE Assembly Map	3	160.0	UniSTS
Whitehead-YAC Contig Map	3		UniSTS

RH25242

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,930,617 - 150,930,739	UniSTS	GRCh37
Build 36	3	152,413,307 - 152,413,429	RGD	NCBI36
Celera	3	149,343,395 - 149,343,517	RGD
Cytogenetic Map	3	q25.1	UniSTS
Cytogenetic Map	3	q24-q25.1	UniSTS
HuRef	3	148,303,654 - 148,303,776	UniSTS
GeneMap99-GB4 RH Map	3	554.51	UniSTS

G54361

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,997,690 - 150,997,895	UniSTS	GRCh37
Build 36	3	152,480,380 - 152,480,585	RGD	NCBI36
Celera	3	149,410,465 - 149,410,670	RGD
Cytogenetic Map	3	q25.1	UniSTS
Cytogenetic Map	3	q24-q25.1	UniSTS
HuRef	3	148,370,594 - 148,370,799	UniSTS

D3S3882

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,930,916 - 150,931,065	UniSTS	GRCh37
Build 36	3	152,413,606 - 152,413,755	RGD	NCBI36
Celera	3	149,343,694 - 149,343,843	RGD
Cytogenetic Map	3	q25.1	UniSTS
Cytogenetic Map	3	q24-q25.1	UniSTS
HuRef	3	148,303,953 - 148,304,102	UniSTS
Stanford-G3 RH Map	3	6853.0	UniSTS
GeneMap99-G3 RH Map	3	7323.0	UniSTS

PMC196132P2

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,930,221 - 150,930,577	UniSTS	GRCh37
Build 36	3	152,412,911 - 152,413,267	RGD	NCBI36
Celera	3	149,342,999 - 149,343,355	RGD
Cytogenetic Map	3	q25.1	UniSTS
Cytogenetic Map	3	q24-q25.1	UniSTS
HuRef	3	148,303,258 - 148,303,614	UniSTS

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,932,991 - 150,933,102	UniSTS	GRCh37
Build 36	3	152,415,681 - 152,415,792	RGD	NCBI36
Celera	3	149,345,769 - 149,345,880	RGD
Cytogenetic Map	3	q25.1	UniSTS
Cytogenetic Map	3	q24-q25.1	UniSTS
HuRef	3	148,306,028 - 148,306,139	UniSTS
TNG Radiation Hybrid Map	3	86079.0	UniSTS

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,930,082 - 150,930,312	UniSTS	GRCh37
Build 36	3	152,412,772 - 152,413,002	RGD	NCBI36
Celera	3	149,342,860 - 149,343,090	RGD
Cytogenetic Map	3	q25.1	UniSTS
Cytogenetic Map	3	q24-q25.1	UniSTS
HuRef	3	148,303,119 - 148,303,349	UniSTS
GeneMap99-GB4 RH Map	3	554.51	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2322	2788	2238	4753	1662	2122	3	572	1602	411	2121	6766	6100	6	3650	803	1645	1444	168	1


RefSeq Transcripts	NG_021244	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001081455	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_014879	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_005247922	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_005247923	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513340	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017007583	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054348643	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054348644	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054348645	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054348646	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AC078816	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AH011260	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK289617	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC034989	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CD110153	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471052	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068275	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CS173021	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	D13626	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	EF577400	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000309170 ⟹ ENSP00000308361

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	151,212,117 - 151,278,542 (-)	Ensembl

Ensembl Acc Id:

ENST00000424796 ⟹ ENSP00000408733

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	151,212,919 - 151,249,114 (-)	Ensembl

Ensembl Acc Id:

ENST00000494668 ⟹ ENSP00000418065

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	151,214,030 - 151,278,369 (-)	Ensembl

RefSeq Acc Id:

NM_001081455 ⟹ NP_001074924

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	151,212,117 - 151,248,991 (-)	NCBI
GRCh37	3	150,929,905 - 150,996,996 (-)	NCBI
Build 36	3	152,412,595 - 152,449,688 (-)	NCBI Archive
HuRef	3	148,302,942 - 148,369,134 (-)	ENTREZGENE
CHM1_1	3	150,893,105 - 150,930,193 (-)	NCBI
T2T-CHM13v2.0	3	153,963,174 - 154,000,058 (-)	NCBI

Sequence:

show sequence

AGTGTTTCCCACTGGTCAACACGAGCAGTCCAGCAGAGAGCAAAATCTATTTCCCTCAACATCAAATGCTACACTCAGTTGCTGATCCTATCTTGCCTACAGAGAACCTAAAAGACTGGAAAAATTGG
ATCTTTAATGAAAAAACACTTGGGCCACTTCAAGACGACAAACGCTCACTGGGCAAAACACCTTCACTGAAAAGAGACCTCATATTATGCAAAAAAAATCTTAAAAGGCCTCTGCCTTCAGAAGTTAC
AAGATGATCAATTCAACCTCCACACAGCCTCCAGATGAATCCTGCTCTCAGAACCTCCTGATCACTCAGCAGATCATTCCTGTGCTGTACTGTATGGTCTTCATTGCAGGAATCCTACTCAATGGAGT
GTCAGGATGGATATTCTTTTACGTGCCCAGCTCTAAGAGTTTCATCATCTATCTCAAGAACATTGTTATTGCTGACTTTGTGATGAGCCTGACTTTTCCTTTCAAGATCCTTGGTGACTCAGGCCTTG
GTCCCTGGCAGCTGAACGTGTTTGTGTGCAGGGTCTCTGCCGTGCTCTTCTACGTCAACATGTACGTCAGCATTGTGTTCTTTGGGCTCATCAGCTTTGACAGATATTATAAAATTGTAAAGCCTCTT
TGGACTTCTTTCATCCAGTCAGTGAGTTACAGCAAACTTCTGTCAGTGATAGTATGGATGCTCATGCTCCTCCTTGCTGTTCCAAATATTATTCTCACCAACCAGAGTGTTAGGGAGGTTACACAAAT
AAAATGTATAGAACTGAAAAGTGAACTGGGACGGAAGTGGCACAAAGCATCAAACTACATCTTCGTGGCCATCTTCTGGATTGTGTTTCTTTTGTTAATCGTTTTCTATACTGCTATCACAAAGAAAA
TCTTTAAGTCCCACCTTAAGTCAAGTCGGAATTCCACTTCGGTCAAAAAGAAATCTAGCCGCAACATATTCAGCATCGTGTTTGTGTTTTTTGTCTGTTTTGTACCTTACCATATTGCCAGAATCCCC
TACACAAAGAGTCAGACCGAAGCTCATTACAGCTGCCAGTCAAAAGAAATCTTGCGGTATATGAAAGAATTCACTCTGCTACTATCTGCTGCAAATGTATGCTTGGACCCTATTATTTATTTCTTTCT
ATGCCAGCCGTTTAGGGAAATCTTATGTAAGAAATTGCACATTCCATTAAAAGCTCAGAATGACCTAGACATTTCCAGAATCAAAAGAGGAAATACAACACTTGAAAGCACAGATACTTTGTGAGTTC
CTACCCTCTTCCAAAGAAAGACCACGTGTGCATGTTGTCATCTTCAATTACATAACAGAAATCAATAAGATATGTGCCCTCATCATAAATATCATCTCTAGCACTGCCATCCAATTTAGTTCAATAAA
ATTCAAATATAAGTTTCCATGCTTTTTTGTAACATCAAAGAAAACATACCCATCAGTAATTTCTCTAATACTGACCTTTCTATTCTCTATTAATAAAAAATTAATACATACAATTATTCAATTCTATT
ATATTAAAATAAGTTAAAGTTTATAACCACTAGTCTGGTCAGTTAATGTAGAAATTTAAATAGTAAATAAAACACAACATAATCAAAGACAACTCACTCAGGCATCTTCTTTCTCTAAATACCAGAAT
CTAGTATGTAATTGTTTTCAACACTGTCCTTAAAGACTAACTTGAAAGCAGGCACAGTTTGATGAAGGGCTAGAGAGCTGTTTGCAATAAAAAGTCAGGTTTTTTTCCTGATTTGAAGAAGCAGGAAA
AGCTGACACCCAGACAATCACTTAAGAAACCCCTTATTGATGTATTTCATGGCACTGCAAAGGAAGAGGAATATTAATTGTATACTTAGCAAGAAAATTTTTTTTTTCTGATAGCACTTTGAGGATAT
TAGATACATGCTAAATATGTTTTCTACAAAGACTTACGTCATTTAATGAGCCTGGGGTTCTGGTGTTAGAATATTTTTAAGTAGGCTTTACTGAGAGAAACTAAATATTGGCATACGTTATCAGCAAC
TTCCCCTGTTCAATAGTATGGGAAAAATAAGATGACTGGGAAAAAGACACACCCACACCGTAGAACATATATTAATCTACTGGCGAATGGGAAAGGAGACCATTTTCTTAGAAAGCAAATAAACTTGA
TTTTTTTAAATCTAAAATTTACATTAATGAGTGCAAAATAACACATAAAATGAAAATTCACACATCACATTTTTCTGGAAAACAGACGGATTTTACTTCTGGAGACATGGCATACGGTTACTGACTTA
TGAGCTACCAAAACTAAATTCTTTCTCTGCTATTAACTGGCTAGAAGACATTCATCTATTTTTCAAATGTTCTTTCAAAACATTTTTATAAGTAATGTTTGTATCTATTTCATGCTTTACTGTCTATA
TACTAATAAAGAAATGTTTTAATACTG

hide sequence

RefSeq Acc Id:

NM_014879 ⟹ NP_055694

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	151,212,117 - 151,278,542 (-)	NCBI
GRCh37	3	150,929,905 - 150,996,996 (-)	NCBI
Build 36	3	152,412,595 - 152,478,920 (-)	NCBI Archive
HuRef	3	148,302,942 - 148,369,134 (-)	ENTREZGENE
CHM1_1	3	150,893,105 - 150,959,426 (-)	NCBI
T2T-CHM13v2.0	3	153,963,174 - 154,029,607 (-)	NCBI

Sequence:

show sequence

AGAAGTCAGCCTAACACCCACAGAGATTAAAACGTCTCTTCCTTCCTCTTTGTTTCCACGTCCC
AGTCTTCAATAAATTCTATCTGACAACAGCAGCAGAGGGACCCACTATCTTGTGGTTTCTGTCAAGTTCCTGATTTTCATCCGTAGTTGAAGATGAGCAAGAACTCTGTAACAGTGTTACCTTGGAGC
CTACAATGAGAGGTATTTCAAAATGAGTGAAGCATGACTCTCACAGATGAAGGCCTAGACGCAGGATCTTTAATGAAAAAACACTTGGGCCACTTCAAGACGACAAACGCTCACTGGGCAAAACACCT
TCACTGAAAAGAGACCTCATATTATGCAAAAAAAATCTTAAAAGGCCTCTGCCTTCAGAAGTTACAAGATGATCAATTCAACCTCCACACAGCCTCCAGATGAATCCTGCTCTCAGAACCTCCTGATC
ACTCAGCAGATCATTCCTGTGCTGTACTGTATGGTCTTCATTGCAGGAATCCTACTCAATGGAGTGTCAGGATGGATATTCTTTTACGTGCCCAGCTCTAAGAGTTTCATCATCTATCTCAAGAACAT
TGTTATTGCTGACTTTGTGATGAGCCTGACTTTTCCTTTCAAGATCCTTGGTGACTCAGGCCTTGGTCCCTGGCAGCTGAACGTGTTTGTGTGCAGGGTCTCTGCCGTGCTCTTCTACGTCAACATGT
ACGTCAGCATTGTGTTCTTTGGGCTCATCAGCTTTGACAGATATTATAAAATTGTAAAGCCTCTTTGGACTTCTTTCATCCAGTCAGTGAGTTACAGCAAACTTCTGTCAGTGATAGTATGGATGCTC
ATGCTCCTCCTTGCTGTTCCAAATATTATTCTCACCAACCAGAGTGTTAGGGAGGTTACACAAATAAAATGTATAGAACTGAAAAGTGAACTGGGACGGAAGTGGCACAAAGCATCAAACTACATCTT
CGTGGCCATCTTCTGGATTGTGTTTCTTTTGTTAATCGTTTTCTATACTGCTATCACAAAGAAAATCTTTAAGTCCCACCTTAAGTCAAGTCGGAATTCCACTTCGGTCAAAAAGAAATCTAGCCGCA
ACATATTCAGCATCGTGTTTGTGTTTTTTGTCTGTTTTGTACCTTACCATATTGCCAGAATCCCCTACACAAAGAGTCAGACCGAAGCTCATTACAGCTGCCAGTCAAAAGAAATCTTGCGGTATATG
AAAGAATTCACTCTGCTACTATCTGCTGCAAATGTATGCTTGGACCCTATTATTTATTTCTTTCTATGCCAGCCGTTTAGGGAAATCTTATGTAAGAAATTGCACATTCCATTAAAAGCTCAGAATGA
CCTAGACATTTCCAGAATCAAAAGAGGAAATACAACACTTGAAAGCACAGATACTTTGTGAGTTCCTACCCTCTTCCAAAGAAAGACCACGTGTGCATGTTGTCATCTTCAATTACATAACAGAAATC
AATAAGATATGTGCCCTCATCATAAATATCATCTCTAGCACTGCCATCCAATTTAGTTCAATAAAATTCAAATATAAGTTTCCATGCTTTTTTGTAACATCAAAGAAAACATACCCATCAGTAATTTC
TCTAATACTGACCTTTCTATTCTCTATTAATAAAAAATTAATACATACAATTATTCAATTCTATTATATTAAAATAAGTTAAAGTTTATAACCACTAGTCTGGTCAGTTAATGTAGAAATTTAAATAG
TAAATAAAACACAACATAATCAAAGACAACTCACTCAGGCATCTTCTTTCTCTAAATACCAGAATCTAGTATGTAATTGTTTTCAACACTGTCCTTAAAGACTAACTTGAAAGCAGGCACAGTTTGAT
GAAGGGCTAGAGAGCTGTTTGCAATAAAAAGTCAGGTTTTTTTCCTGATTTGAAGAAGCAGGAAAAGCTGACACCCAGACAATCACTTAAGAAACCCCTTATTGATGTATTTCATGGCACTGCAAAGG
AAGAGGAATATTAATTGTATACTTAGCAAGAAAATTTTTTTTTTCTGATAGCACTTTGAGGATATTAGATACATGCTAAATATGTTTTCTACAAAGACTTACGTCATTTAATGAGCCTGGGGTTCTGG
TGTTAGAATATTTTTAAGTAGGCTTTACTGAGAGAAACTAAATATTGGCATACGTTATCAGCAACTTCCCCTGTTCAATAGTATGGGAAAAATAAGATGACTGGGAAAAAGACACACCCACACCGTAG
AACATATATTAATCTACTGGCGAATGGGAAAGGAGACCATTTTCTTAGAAAGCAAATAAACTTGATTTTTTTAAATCTAAAATTTACATTAATGAGTGCAAAATAACACATAAAATGAAAATTCACAC
ATCACATTTTTCTGGAAAACAGACGGATTTTACTTCTGGAGACATGGCATACGGTTACTGACTTATGAGCTACCAAAACTAAATTCTTTCTCTGCTATTAACTGGCTAGAAGACATTCATCTATTTTT
CAAATGTTCTTTCAAAACATTTTTATAAGTAATGTTTGTATCTATTTCATGCTTTACTGTCTATATACTAATAAAGAAATGTTTTAATACTG

hide sequence

RefSeq Acc Id:

XM_005247922 ⟹ XP_005247979

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	151,212,117 - 151,278,542 (-)	NCBI
GRCh37	3	150,929,905 - 150,996,996 (-)	NCBI

Sequence:

show sequence

AACAGTGTTACCTTGGAGCCTACAATGAGAGGTATTTCAAAATGAGTGAAGCATGACTCTCACAGATGAAGGCCTAGACGCAGGAATTACCTAGCAAGCCATGGCCACCATCCCTCTTACCCTCCACA
ATTCCAGGATCTTTAATGAAAAAACACTTGGGCCACTTCAAGACGACAAACGCTCACTGGGCAAAACACCTTCACTGAAAAGAGACCTCATATTATGCAAAAAAAATCTTAAAAGGCCTCTGCCTTCA
GAAGTTACAAGATGATCAATTCAACCTCCACACAGCCTCCAGATGAATCCTGCTCTCAGAACCTCCTGATCACTCAGCAGATCATTCCTGTGCTGTACTGTATGGTCTTCATTGCAGGAATCCTACTC
AATGGAGTGTCAGGATGGATATTCTTTTACGTGCCCAGCTCTAAGAGTTTCATCATCTATCTCAAGAACATTGTTATTGCTGACTTTGTGATGAGCCTGACTTTTCCTTTCAAGATCCTTGGTGACTC
AGGCCTTGGTCCCTGGCAGCTGAACGTGTTTGTGTGCAGGGTCTCTGCCGTGCTCTTCTACGTCAACATGTACGTCAGCATTGTGTTCTTTGGGCTCATCAGCTTTGACAGATATTATAAAATTGTAA
AGCCTCTTTGGACTTCTTTCATCCAGTCAGTGAGTTACAGCAAACTTCTGTCAGTGATAGTATGGATGCTCATGCTCCTCCTTGCTGTTCCAAATATTATTCTCACCAACCAGAGTGTTAGGGAGGTT
ACACAAATAAAATGTATAGAACTGAAAAGTGAACTGGGACGGAAGTGGCACAAAGCATCAAACTACATCTTCGTGGCCATCTTCTGGATTGTGTTTCTTTTGTTAATCGTTTTCTATACTGCTATCAC
AAAGAAAATCTTTAAGTCCCACCTTAAGTCAAGTCGGAATTCCACTTCGGTCAAAAAGAAATCTAGCCGCAACATATTCAGCATCGTGTTTGTGTTTTTTGTCTGTTTTGTACCTTACCATATTGCCA
GAATCCCCTACACAAAGAGTCAGACCGAAGCTCATTACAGCTGCCAGTCAAAAGAAATCTTGCGGTATATGAAAGAATTCACTCTGCTACTATCTGCTGCAAATGTATGCTTGGACCCTATTATTTAT
TTCTTTCTATGCCAGCCGTTTAGGGAAATCTTATGTAAGAAATTGCACATTCCATTAAAAGCTCAGAATGACCTAGACATTTCCAGAATCAAAAGAGGAAATACAACACTTGAAAGCACAGATACTTT
GTGAGTTCCTACCCTCTTCCAAAGAAAGACCACGTGTGCATGTTGTCATCTTCAATTACATAACAGAAATCAATAAGATATGTGCCCTCATCATAAATATCATCTCTAGCACTGCCATCCAATTTAGT
TCAATAAAATTCAAATATAAGTTTCCATGCTTTTTTGTAACATCAAAGAAAACATACCCATCAGTAATTTCTCTAATACTGACCTTTCTATTCTCTATTAATAAAAAATTAATACATACAATTATTCA
ATTCTATTATATTAAAATAAGTTAAAGTTTATAACCACTAGTCTGGTCAGTTAATGTAGAAATTTAAATAGTAAATAAAACACAACATAATCAAAGACAACTCACTCAGGCATCTTCTTTCTCTAAAT
ACCAGAATCTAGTATGTAATTGTTTTCAACACTGTCCTTAAAGACTAACTTGAAAGCAGGCACAGTTTGATGAAGGGCTAGAGAGCTGTTTGCAATAAAAAGTCAGGTTTTTTTCCTGATTTGAAGAA
GCAGGAAAAGCTGACACCCAGACAATCACTTAAGAAACCCCTTATTGATGTATTTCATGGCACTGCAAAGGAAGAGGAATATTAATTGTATACTTAGCAAGAAAATTTTTTTTTTCTGATAGCACTTT
GAGGATATTAGATACATGCTAAATATGTTTTCTACAAAGACTTACGTCATTTAATGAGCCTGGGGTTCTGGTGTTAGAATATTTTTAAGTAGGCTTTACTGAGAGAAACTAAATATTGGCATACGTTA
TCAGCAACTTCCCCTGTTCAATAGTATGGGAAAAATAAGATGACTGGGAAAAAGACACACCCACACCGTAGAACATATATTAATCTACTGGCGAATGGGAAAGGAGACCATTTTCTTAGAAAGCAAAT
AAACTTGATTTTTTTAAATCTAAAATTTACATTAATGAGTGCAAAATAACACATAAAATGAAAATTCACACATCACATTTTTCTGGAAAACAGACGGATTTTACTTCTGGAGACATGGCATACGGTTA
CTGACTTATGAGCTACCAAAACTAAATTCTTTCTCTGCTATTAACTGGCTAGAAGACATTCATCTATTTTTCAAATGTTCTTTCAAAACATTTTTATAAGTAATGTTTGTATCTATTTCATGCTTTAC
TGTCTATATACTAATAAAGAAATGTTTTAATACTGTC

hide sequence

RefSeq Acc Id:

XM_005247923 ⟹ XP_005247980

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	151,212,117 - 151,248,991 (-)	NCBI
GRCh37	3	150,929,905 - 150,996,996 (-)	NCBI

Sequence:

show sequence

ATGGGTAGATGGTATTATCACAAATTGAGAGAGACACATTGAGTAGGAAGAACCCAAGAAGCAT
CTGGGTAGAAAGGTGCAAGGAACAACAGTGTACAGAGGTGCAAGGTGGTGAGAGATGCTGGCAGAGATGTCACAAGTGCTAACAGGGCAGGGCAAGGGCAGAGAAAGGCAAAAGCATGGGGCTCAGGA
TGGAATCCATAAAACATCAACATTTGAGGGCAAGCCCTTAATCATGGAGGGAACAGTGTCAGAAAGGTACAAGGGCAGTATGCCAAAGTACCACAGAGAGAATCATCATCAAAAGCTGCCTTAATGCC
TCATACCCATTAAGATGGCTACTACTAGAAAGAAAGAACAAACACAACACACAAATGGAAAACAAGTGTTAGCAAGGATGTGGGGAAAGTGACACCTTTGTGCACTGTTGGTGGGAACGTAAGATGGT
TCATTCAGCCTCTATGGAAAACAGCAATTCCTTTAGAAAATTAACATAGGATTACCACATGATCCAGCAATTTTGCTTCTGGGCACATAACCAAAAGAACTGAAAGTAGGGTCTTAAGCAGATATTTG
TATACCCACTTTCATAGCAGCATTGTTCACAATAGCCAAAAGGTGGATGCTACCCAAGGACTATGGACAGATGAATAAACAAAATGTGGTATATACATAGAGCGGAATATTATTCAGTCTTAAAAAGA
AATGAATTGTCACATGCTACAAAATGCATGAACCTTAAAGACATTATGCTAAGTGAATTAAGCCAGTCAAAAAAGGACAAATACTGTATGATTCCACTTCTATGAGATAGCTAGAGTATTCAACTTCG
TAGAGAAGAACAGTAGTTACCAGGGACTAGGGGCAAGGATAAATGGAGAATTATTATTTAATGGGTACAGAATTTTAGTTTTGCAAGATGAAAACAGTTCTAGAGATGCATGGTGATGATGGTTACAC
AACAATGTGAATGTAATTAACGTCACTGAACACTTAAAAATAGTTAAGGTGGCAAATGTTATGTGTATTTCACCACAATCCCAAAAAAGCTACCTCAAAGACAAAAAAAATCTTTCAAAATGTCAATT
GGATTGAGGAATGTGCAATGAGGAGGTCTTTGGCAGTTCTAGATAAGTGCTGAGGACAGAAGGCAGAGTGGACTAGATTACAGAGTGAATGGGAAAGTGGAGACAGCAAACGCAGACCATTTCCAACA
AGTTTGGATAAGGAGATAAAGGTACCGACTGGATGATTGCTAATAAAGAGGATTCACATTTAAGGGAGAGCTTTGAGGGTTTTCGCTTTATTTTATTTGATAATGATAACAGGCATGATTGATCGTGA
GCATGCCTCTCTAGGACAGAAGGAAAGAAACTGGTAAAATGGGAAAAGTTGATGCTATAGGCCCTAAACTGGATGAATTCAAGTAGACGGAGTATAGGAGACTCAGGCCTTTCCTTCTGAAAGATGTA
TTATGACTGTATTAATCCAGAGCATAATTTCAGAAATCCCCAGGAAGAACTTGTTAAAGAAGGAAATATCCAGGCATTGGGATCAAGTAACAACCCAGGACAGAAACAGAATGTTGTGAAACCAGATT
TAAGTCAAGGAGTAATACGAAGAATGATTGGAGACCCAAAAGCCCCCATTCAAGGCTGGAAATGTGTCAGGATAACAGATGGAGTAGAAGAGGTACTGGCATGCATCAAGTCCATCCCTAGACCAGGA
TAAGTCTAGAGGAGCAAATCCCCCAAGTCCCAGAGGAGATAGCATAGTCTTGGGGTCCTTTCAATATCTCTTCTCATTTGACAGTTATCTTGCCCTGCACCAATCAAGACCCCCAAGTTAACACCTAC
TTAAACAGCTTTCCTGCCTCCTCCCCTGGTACTGAAAGAAGGAAACGTGCAGATGTTTTACTCTCAAATATTTTTTGGTTTTCCAACTAATTTCAAGGAATTAGTTTGAAACCATGTGAATTACAACT
TAAAAATACTTCCCAATAAATACAGAAGCTATTATTACAACAGCTTCACAGGAAAAGGTCATAAACAAGCATGGGAAAGATCTATCTTCCTGCTGGCTGGAGCTCTCACTTGCTCAGTCTCCCTTTTC
ACAGCTGGTTTCATACTATTTACTATTTGGTCAAGCCGTGCTAATCTGTAACCCTAAGCAAATCCAAATCAGGTCCAACTTATGCAAGCATATATTAGAGCTGGGCTCCAAAGAATACTGGACATCTG
TAGTACCTGACATTCAAGCATTTGGCGAGATGTCAATATTTCAGAGAGCACTTTAAATGTTTTGATTTGAAAGCTAATGCAGTGTTTCCCACTGGTCAACACGAGCAGTCCAGCAGAGAGCAAAATCT
ATTTCCCTCAACATCAAATGCTACACTCAGTTGCTGATCCTATCTTGCCTACAGAGAACCTAAAAGACTGGAAAAATTGGCCTCTGCCTTCAGAAGTTACAAGATGATCAATTCAACCTCCACACAGC
CTCCAGATGAATCCTGCTCTCAGAACCTCCTGATCACTCAGCAGATCATTCCTGTGCTGTACTGTATGGTCTTCATTGCAGGAATCCTACTCAATGGAGTGTCAGGATGGATATTCTTTTACGTGCCC
AGCTCTAAGAGTTTCATCATCTATCTCAAGAACATTGTTATTGCTGACTTTGTGATGAGCCTGACTTTTCCTTTCAAGATCCTTGGTGACTCAGGCCTTGGTCCCTGGCAGCTGAACGTGTTTGTGTG
CAGGGTCTCTGCCGTGCTCTTCTACGTCAACATGTACGTCAGCATTGTGTTCTTTGGGCTCATCAGCTTTGACAGATATTATAAAATTGTAAAGCCTCTTTGGACTTCTTTCATCCAGTCAGTGAGTT
ACAGCAAACTTCTGTCAGTGATAGTATGGATGCTCATGCTCCTCCTTGCTGTTCCAAATATTATTCTCACCAACCAGAGTGTTAGGGAGGTTACACAAATAAAATGTATAGAACTGAAAAGTGAACTG
GGACGGAAGTGGCACAAAGCATCAAACTACATCTTCGTGGCCATCTTCTGGATTGTGTTTCTTTTGTTAATCGTTTTCTATACTGCTATCACAAAGAAAATCTTTAAGTCCCACCTTAAGTCAAGTCG
GAATTCCACTTCGGTCAAAAAGAAATCTAGCCGCAACATATTCAGCATCGTGTTTGTGTTTTTTGTCTGTTTTGTACCTTACCATATTGCCAGAATCCCCTACACAAAGAGTCAGACCGAAGCTCATT
ACAGCTGCCAGTCAAAAGAAATCTTGCGGTATATGAAAGAATTCACTCTGCTACTATCTGCTGCAAATGTATGCTTGGACCCTATTATTTATTTCTTTCTATGCCAGCCGTTTAGGGAAATCTTATGT
AAGAAATTGCACATTCCATTAAAAGCTCAGAATGACCTAGACATTTCCAGAATCAAAAGAGGAAATACAACACTTGAAAGCACAGATACTTTGTGAGTTCCTACCCTCTTCCAAAGAAAGACCACGTG
TGCATGTTGTCATCTTCAATTACATAACAGAAATCAATAAGATATGTGCCCTCATCATAAATATCATCTCTAGCACTGCCATCCAATTTAGTTCAATAAAATTCAAATATAAGTTTCCATGCTTTTTT
GTAACATCAAAGAAAACATACCCATCAGTAATTTCTCTAATACTGACCTTTCTATTCTCTATTAATAAAAAATTAATACATACAATTATTCAATTCTATTATATTAAAATAAGTTAAAGTTTATAACC
ACTAGTCTGGTCAGTTAATGTAGAAATTTAAATAGTAAATAAAACACAACATAATCAAAGACAACTCACTCAGGCATCTTCTTTCTCTAAATACCAGAATCTAGTATGTAATTGTTTTCAACACTGTC
CTTAAAGACTAACTTGAAAGCAGGCACAGTTTGATGAAGGGCTAGAGAGCTGTTTGCAATAAAAAGTCAGGTTTTTTTCCTGATTTGAAGAAGCAGGAAAAGCTGACACCCAGACAATCACTTAAGAA
ACCCCTTATTGATGTATTTCATGGCACTGCAAAGGAAGAGGAATATTAATTGTATACTTAGCAAGAAAATTTTTTTTTTCTGATAGCACTTTGAGGATATTAGATACATGCTAAATATGTTTTCTACA
AAGACTTACGTCATTTAATGAGCCTGGGGTTCTGGTGTTAGAATATTTTTAAGTAGGCTTTACTGAGAGAAACTAAATATTGGCATACGTTATCAGCAACTTCCCCTGTTCAATAGTATGGGAAAAAT
AAGATGACTGGGAAAAAGACACACCCACACCGTAGAACATATATTAATCTACTGGCGAATGGGAAAGGAGACCATTTTCTTAGAAAGCAAATAAACTTGATTTTTTTAAATCTAAAATTTACATTAAT
GAGTGCAAAATAACACATAAAATGAAAATTCACACATCACATTTTTCTGGAAAACAGACGGATTTTACTTCTGGAGACATGGCATACGGTTACTGACTTATGAGCTACCAAAACTAAATTCTTTCTCT
GCTATTAACTGGCTAGAAGACATTCATCTATTTTTCAAATGTTCTTTCAAAACATTTTTATAAGTAATGTTTGTATCTATTTCATGCTTTACTGTCTATATACTAATAAAGAAATGTTTTAATACTGT
C

hide sequence

RefSeq Acc Id:

XM_011513340 ⟹ XP_011511642

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	151,212,117 - 151,278,542 (-)	NCBI

Sequence:

show sequence

TTCTTTCTGGTTCTGAGTTATACACTTTGAAGAGGACTTTGTAGCCATCTTCTGAAAACTTCCA
AATCTAATGGCACTAATAGTCAATGGGAAAGACAGTGGAGCACTGCAGGACATCACCAATTATATTACAGAGCCTGAAAGGAACTAAAAATATGAAGACTTTCAAAATAGTAACACAGCACAAACACC
AAAATGTTAACACACGAGGAGTTTATCTGAAGTCCTACTTGTGATCTATTTATCAGTAATGTTCAAATATGGGAAAATTAATGTGGGAAAAATGACAATGCAACACCTCTTATCTAGAATATGTCGAC
ATTGGTGTCAAAATACTTCTTTATTCTGTTAATTCCGCATTTCCAGGTAGCTCCAACTACCCATCTCTGCACGTTATACTGTGAAGCTGCTGACAATTTTCTGAGGGTGCTTCAGAAAGAACCATATC
TTACACATCAGTTCTCCACCTCATACCACATGTTGAATTTGACAATGGCAAAGGTTAGAAAAGAAAACAGGTTTTTGCCTGGCTGTGCATCAGATGATGTAGGGATGTGGGGAAAAGTAGGAGGAGAA
ATAAGAAAGCAGGACTGTTTTTGCATTACTGGAGGAAAGGAACTAGCTCAGAAGTCAGCCTAACACCCACAGAGATTAAAACGTCTCTTCCTTCCTCTTTGTTTCCACGTCCCAGTCTTCAATAAATT
CTATCTGACAACAGCAGCAGAGGGACCCACTATCTTGTGGTTTCTGTCAAGTTCCTGATTTTCATCCGTAGTTGAAGATGAGCAAGAACTCTGTAACAGTGTTACCTTGGAGCCTACAATGAGAGGTA
TTTCAAAATGAGTGAAGCATGACTCTCACAGATGAAGGCCTAGACGCAGGCCTCTGCCTTCAGAAGTTACAAGATGATCAATTCAACCTCCACACAGCCTCCAGATGAATCCTGCTCTCAGAACCTCC
TGATCACTCAGCAGATCATTCCTGTGCTGTACTGTATGGTCTTCATTGCAGGAATCCTACTCAATGGAGTGTCAGGATGGATATTCTTTTACGTGCCCAGCTCTAAGAGTTTCATCATCTATCTCAAG
AACATTGTTATTGCTGACTTTGTGATGAGCCTGACTTTTCCTTTCAAGATCCTTGGTGACTCAGGCCTTGGTCCCTGGCAGCTGAACGTGTTTGTGTGCAGGGTCTCTGCCGTGCTCTTCTACGTCAA
CATGTACGTCAGCATTGTGTTCTTTGGGCTCATCAGCTTTGACAGATATTATAAAATTGTAAAGCCTCTTTGGACTTCTTTCATCCAGTCAGTGAGTTACAGCAAACTTCTGTCAGTGATAGTATGGA
TGCTCATGCTCCTCCTTGCTGTTCCAAATATTATTCTCACCAACCAGAGTGTTAGGGAGGTTACACAAATAAAATGTATAGAACTGAAAAGTGAACTGGGACGGAAGTGGCACAAAGCATCAAACTAC
ATCTTCGTGGCCATCTTCTGGATTGTGTTTCTTTTGTTAATCGTTTTCTATACTGCTATCACAAAGAAAATCTTTAAGTCCCACCTTAAGTCAAGTCGGAATTCCACTTCGGTCAAAAAGAAATCTAG
CCGCAACATATTCAGCATCGTGTTTGTGTTTTTTGTCTGTTTTGTACCTTACCATATTGCCAGAATCCCCTACACAAAGAGTCAGACCGAAGCTCATTACAGCTGCCAGTCAAAAGAAATCTTGCGGT
ATATGAAAGAATTCACTCTGCTACTATCTGCTGCAAATGTATGCTTGGACCCTATTATTTATTTCTTTCTATGCCAGCCGTTTAGGGAAATCTTATGTAAGAAATTGCACATTCCATTAAAAGCTCAG
AATGACCTAGACATTTCCAGAATCAAAAGAGGAAATACAACACTTGAAAGCACAGATACTTTGTGAGTTCCTACCCTCTTCCAAAGAAAGACCACGTGTGCATGTTGTCATCTTCAATTACATAACAG
AAATCAATAAGATATGTGCCCTCATCATAAATATCATCTCTAGCACTGCCATCCAATTTAGTTCAATAAAATTCAAATATAAGTTTCCATGCTTTTTTGTAACATCAAAGAAAACATACCCATCAGTA
ATTTCTCTAATACTGACCTTTCTATTCTCTATTAATAAAAAATTAATACATACAATTATTCAATTCTATTATATTAAAATAAGTTAAAGTTTATAACCACTAGTCTGGTCAGTTAATGTAGAAATTTA
AATAGTAAATAAAACACAACATAATCAAAGACAACTCACTCAGGCATCTTCTTTCTCTAAATACCAGAATCTAGTATGTAATTGTTTTCAACACTGTCCTTAAAGACTAACTTGAAAGCAGGCACAGT
TTGATGAAGGGCTAGAGAGCTGTTTGCAATAAAAAGTCAGGTTTTTTTCCTGATTTGAAGAAGCAGGAAAAGCTGACACCCAGACAATCACTTAAGAAACCCCTTATTGATGTATTTCATGGCACTGC
AAAGGAAGAGGAATATTAATTGTATACTTAGCAAGAAAATTTTTTTTTTCTGATAGCACTTTGAGGATATTAGATACATGCTAAATATGTTTTCTACAAAGACTTACGTCATTTAATGAGCCTGGGGT
TCTGGTGTTAGAATATTTTTAAGTAGGCTTTACTGAGAGAAACTAAATATTGGCATACGTTATCAGCAACTTCCCCTGTTCAATAGTATGGGAAAAATAAGATGACTGGGAAAAAGACACACCCACAC
CGTAGAACATATATTAATCTACTGGCGAATGGGAAAGGAGACCATTTTCTTAGAAAGCAAATAAACTTGATTTTTTTAAATCTAAAATTTACATTAATGAGTGCAAAATAACACATAAAATGAAAATT
CACACATCACATTTTTCTGGAAAACAGACGGATTTTACTTCTGGAGACATGGCATACGGTTACTGACTTATGAGCTACCAAAACTAAATTCTTTCTCTGCTATTAACTGGCTAGAAGACATTCATCTA
TTTTTCAAATGTTCTTTCAAAACATTTTTATAAGTAATGTTTGTATCTATTTCATGCTTTACTGTCTATATACTAATAAAGAAATGTTTTAATACTGTC

hide sequence

RefSeq Acc Id:

XM_017007583 ⟹ XP_016863072

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	151,212,117 - 151,278,542 (-)	NCBI

Sequence:

show sequence

TTCTGGTTCTGAGTTATACACTTTGAAGAGGACTTTGTAGCCATCTTCTGAAAACTTCCAAATCTAATGGCACTAATAGTCAATGGGAAAGACAGTGGAGCACTGCAGGACATCACCAATTATATTAC
AGAGCCTGAAAGGAACTAAAAATATGAAGACTTTCAAAATAGTAACACAGCACAAACACCAAAATGTTAACACACGAGGAGTTTATCTGAAGTCCTACTTGTGATCTATTTATCAGTAATGTTCAAAT
ATGGGAAAATTAATGTGGGAAAAATGACAATGCAACACCTCTTATCTAGAATATGTCGACATTGGTGTCAAAATACTTCTTTATTCTGTTAATTCCGCATTTCCAGGTAGCTCCAACTACCCATCTCT
GCACGTTATACTGTGAAGCTGCTGACAATTTTCTGAGGGTGCTTCAGAAAGAACCATATCTTACACATCAGTTCTCCACCTCATACCACATGTTGAATTTGACAATGGCAAAGGTTAGAAAAGAAAAC
AGGTTTTTGCCTGGCTGTGCATCAGATGATGTAGGGATGTGGGGAAAAGTAGGAGGAGAAATAAGAAAGCAGGACTGTTTTTGCATTACTGGAGGAAAGGAACTAGCTCAGAAGTCAGCCTAACACCC
ACAGAGATTAAAACGTCTCTTCCTTCCTCTTTGTTTCCACGTCCCAGTCTTCAATAAATTCTATCTGACAACAGCAGCAGAGGGACCCACTATCTTGTGGTTTCTGTCAAGTTCCTGATTTTCATCCG
TAGTTGAAGATGAGCAAGAACTCTGTAACAGTGTTACCTTGGAGCCTACAATGAGAGGTATTTCAAAATGAGTGAAGCATGACTCTCACAGATGAAGGCCTAGACGCAGGATTTCCAATCGTGGCTGT
CAAAATATATCTGTGATGAAGAGATATCAAGGAAAATGTTTAAAAGGATCTTTAATGAAAAAACACTTGGGCCACTTCAAGACGACAAACGCTCACTGGGCAAAACACCTTCACTGAAAAGAGACCTC
ATATTATGCAAAAAAAATCTTAAAAGGCCTCTGCCTTCAGAAGTTACAAGATGATCAATTCAACCTCCACACAGCCTCCAGATGAATCCTGCTCTCAGAACCTCCTGATCACTCAGCAGATCATTCCT
GTGCTGTACTGTATGGTCTTCATTGCAGGAATCCTACTCAATGGAGTGTCAGGATGGATATTCTTTTACGTGCCCAGCTCTAAGAGTTTCATCATCTATCTCAAGAACATTGTTATTGCTGACTTTGT
GATGAGCCTGACTTTTCCTTTCAAGATCCTTGGTGACTCAGGCCTTGGTCCCTGGCAGCTGAACGTGTTTGTGTGCAGGGTCTCTGCCGTGCTCTTCTACGTCAACATGTACGTCAGCATTGTGTTCT
TTGGGCTCATCAGCTTTGACAGATATTATAAAATTGTAAAGCCTCTTTGGACTTCTTTCATCCAGTCAGTGAGTTACAGCAAACTTCTGTCAGTGATAGTATGGATGCTCATGCTCCTCCTTGCTGTT
CCAAATATTATTCTCACCAACCAGAGTGTTAGGGAGGTTACACAAATAAAATGTATAGAACTGAAAAGTGAACTGGGACGGAAGTGGCACAAAGCATCAAACTACATCTTCGTGGCCATCTTCTGGAT
TGTGTTTCTTTTGTTAATCGTTTTCTATACTGCTATCACAAAGAAAATCTTTAAGTCCCACCTTAAGTCAAGTCGGAATTCCACTTCGGTCAAAAAGAAATCTAGCCGCAACATATTCAGCATCGTGT
TTGTGTTTTTTGTCTGTTTTGTACCTTACCATATTGCCAGAATCCCCTACACAAAGAGTCAGACCGAAGCTCATTACAGCTGCCAGTCAAAAGAAATCTTGCGGTATATGAAAGAATTCACTCTGCTA
CTATCTGCTGCAAATGTATGCTTGGACCCTATTATTTATTTCTTTCTATGCCAGCCGTTTAGGGAAATCTTATGTAAGAAATTGCACATTCCATTAAAAGCTCAGAATGACCTAGACATTTCCAGAAT
CAAAAGAGGAAATACAACACTTGAAAGCACAGATACTTTGTGAGTTCCTACCCTCTTCCAAAGAAAGACCACGTGTGCATGTTGTCATCTTCAATTACATAACAGAAATCAATAAGATATGTGCCCTC
ATCATAAATATCATCTCTAGCACTGCCATCCAATTTAGTTCAATAAAATTCAAATATAAGTTTCCATGCTTTTTTGTAACATCAAAGAAAACATACCCATCAGTAATTTCTCTAATACTGACCTTTCT
ATTCTCTATTAATAAAAAATTAATACATACAATTATTCAATTCTATTATATTAAAATAAGTTAAAGTTTATAACCACTAGTCTGGTCAGTTAATGTAGAAATTTAAATAGTAAATAAAACACAACATA
ATCAAAGACAACTCACTCAGGCATCTTCTTTCTCTAAATACCAGAATCTAGTATGTAATTGTTTTCAACACTGTCCTTAAAGACTAACTTGAAAGCAGGCACAGTTTGATGAAGGGCTAGAGAGCTGT
TTGCAATAAAAAGTCAGGTTTTTTTCCTGATTTGAAGAAGCAGGAAAAGCTGACACCCAGACAATCACTTAAGAAACCCCTTATTGATGTATTTCATGGCACTGCAAAGGAAGAGGAATATTAATTGT
ATACTTAGCAAGAAAATTTTTTTTTTCTGATAGCACTTTGAGGATATTAGATACATGCTAAATATGTTTTCTACAAAGACTTACGTCATTTAATGAGCCTGGGGTTCTGGTGTTAGAATATTTTTAAG
TAGGCTTTACTGAGAGAAACTAAATATTGGCATACGTTATCAGCAACTTCCCCTGTTCAATAGTATGGGAAAAATAAGATGACTGGGAAAAAGACACACCCACACCGTAGAACATATATTAATCTACT
GGCGAATGGGAAAGGAGACCATTTTCTTAGAAAGCAAATAAACTTGATTTTTTTAAATCTAAAATTTACATTAATGAGTGCAAAATAACACATAAAATGAAAATTCACACATCACATTTTTCTGGAAA
ACAGACGGATTTTACTTCTGGAGACATGGCATACGGTTACTGACTTATGAGCTACCAAAACTAAATTCTTTCTCTGCTATTAACTGGCTAGAAGACATTCATCTATTTTTCAAATGTTCTTTCAAAAC
ATTTTTATAAGTAATGTTTGTATCTATTTCATGCTTTACTGTCTATATACTAATAAAGAAATGTTTTAATACTGTC

hide sequence

RefSeq Acc Id:

XM_054348643 ⟹ XP_054204618

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	3	153,963,174 - 154,029,607 (-)	NCBI

RefSeq Acc Id:

XM_054348644 ⟹ XP_054204619

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	3	153,963,174 - 154,029,607 (-)	NCBI

RefSeq Acc Id:

XM_054348645 ⟹ XP_054204620

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	3	153,963,174 - 154,029,607 (-)	NCBI

RefSeq Acc Id:

XM_054348646 ⟹ XP_054204621

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	3	153,963,174 - 154,000,058 (-)	NCBI


Protein RefSeqs	NP_001074924	(Get FASTA)	NCBI Sequence Viewer
	NP_055694	(Get FASTA)	NCBI Sequence Viewer
	XP_005247979	(Get FASTA)	NCBI Sequence Viewer
	XP_005247980	(Get FASTA)	NCBI Sequence Viewer
	XP_011511642	(Get FASTA)	NCBI Sequence Viewer
	XP_016863072	(Get FASTA)	NCBI Sequence Viewer
	XP_054204618	(Get FASTA)	NCBI Sequence Viewer
	XP_054204619	(Get FASTA)	NCBI Sequence Viewer
	XP_054204620	(Get FASTA)	NCBI Sequence Viewer
	XP_054204621	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAH34989	(Get FASTA)	NCBI Sequence Viewer
	AAL47764	(Get FASTA)	NCBI Sequence Viewer
	ABQ52420	(Get FASTA)	NCBI Sequence Viewer
	BAA02791	(Get FASTA)	NCBI Sequence Viewer
	BAF82306	(Get FASTA)	NCBI Sequence Viewer
	CAJ33692	(Get FASTA)	NCBI Sequence Viewer
	EAW78809	(Get FASTA)	NCBI Sequence Viewer
	EAW78810	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000308361
	ENSP00000308361.3
	ENSP00000408733
	ENSP00000408733.2
GenBank Protein	Q15391	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_055694 ⟸ NM_014879

- UniProtKB:

Q8IYT7 (UniProtKB/Swiss-Prot), Q15391 (UniProtKB/Swiss-Prot), A5JUU3 (UniProtKB/TrEMBL)

- Sequence:

show sequence

MINSTSTQPPDESCSQNLLITQQIIPVLYCMVFIAGILLNGVSGWIFFYVPSSKSFIIYLKNIVIADFVMSLTFPFKILGDSGLGPWQLNVFVCRVSAVLFYVNMYVSIVFFGLISFDRYYKIVKPLW
TSFIQSVSYSKLLSVIVWMLMLLLAVPNIILTNQSVREVTQIKCIELKSELGRKWHKASNYIFVAIFWIVFLLLIVFYTAITKKIFKSHLKSSRNSTSVKKKSSRNIFSIVFVFFVCFVPYHIARIPY
TKSQTEAHYSCQSKEILRYMKEFTLLLSAANVCLDPIIYFFLCQPFREILCKKLHIPLKAQNDLDISRIKRGNTTLESTDTL

hide sequence

RefSeq Acc Id:

NP_001074924 ⟸ NM_001081455

- UniProtKB:

Q8IYT7 (UniProtKB/Swiss-Prot), Q15391 (UniProtKB/Swiss-Prot), A5JUU3 (UniProtKB/TrEMBL)

- Sequence:

show sequence

MINSTSTQPPDESCSQNLLITQQIIPVLYCMVFIAGILLNGVSGWIFFYVPSSKSFIIYLKNIVIADFVMSLTFPFKILGDSGLGPWQLNVFVCRVSAVLFYVNMYVSIVFFGLISFDRYYKIVKPLW
TSFIQSVSYSKLLSVIVWMLMLLLAVPNIILTNQSVREVTQIKCIELKSELGRKWHKASNYIFVAIFWIVFLLLIVFYTAITKKIFKSHLKSSRNSTSVKKKSSRNIFSIVFVFFVCFVPYHIARIPY
TKSQTEAHYSCQSKEILRYMKEFTLLLSAANVCLDPIIYFFLCQPFREILCKKLHIPLKAQNDLDISRIKRGNTTLESTDTL

hide sequence

RefSeq Acc Id:	XP_005247979 ⟸ XM_005247922
- Peptide Label:	isoform X1
- UniProtKB:	Q8IYT7 (UniProtKB/Swiss-Prot), Q15391 (UniProtKB/Swiss-Prot), A5JUU3 (UniProtKB/TrEMBL)
- Sequence:	show sequence MINSTSTQPPDESCSQNLLITQQIIPVLYCMVFIAGILLNGVSGWIFFYVPSSKSFIIYLKNIVIADFVMSLTFPFKILGDSGLGPWQLNVFVCRVSAVLFYVNMYVSIVFFGLISFDRYYKIVKPLW TSFIQSVSYSKLLSVIVWMLMLLLAVPNIILTNQSVREVTQIKCIELKSELGRKWHKASNYIFVAIFWIVFLLLIVFYTAITKKIFKSHLKSSRNSTSVKKKSSRNIFSIVFVFFVCFVPYHIARIPY TKSQTEAHYSCQSKEILRYMKEFTLLLSAANVCLDPIIYFFLCQPFREILCKKLHIPLKAQNDLDISRIKRGNTTLESTDTL hide sequence

RefSeq Acc Id:	XP_005247980 ⟸ XM_005247923
- Peptide Label:	isoform X1
- UniProtKB:	Q8IYT7 (UniProtKB/Swiss-Prot), Q15391 (UniProtKB/Swiss-Prot), A5JUU3 (UniProtKB/TrEMBL)
- Sequence:	show sequence MINSTSTQPPDESCSQNLLITQQIIPVLYCMVFIAGILLNGVSGWIFFYVPSSKSFIIYLKNIVIADFVMSLTFPFKILGDSGLGPWQLNVFVCRVSAVLFYVNMYVSIVFFGLISFDRYYKIVKPLW TSFIQSVSYSKLLSVIVWMLMLLLAVPNIILTNQSVREVTQIKCIELKSELGRKWHKASNYIFVAIFWIVFLLLIVFYTAITKKIFKSHLKSSRNSTSVKKKSSRNIFSIVFVFFVCFVPYHIARIPY TKSQTEAHYSCQSKEILRYMKEFTLLLSAANVCLDPIIYFFLCQPFREILCKKLHIPLKAQNDLDISRIKRGNTTLESTDTL hide sequence

RefSeq Acc Id:	XP_011511642 ⟸ XM_011513340
- Peptide Label:	isoform X1
- UniProtKB:	Q8IYT7 (UniProtKB/Swiss-Prot), Q15391 (UniProtKB/Swiss-Prot), A5JUU3 (UniProtKB/TrEMBL)
- Sequence:	show sequence MINSTSTQPPDESCSQNLLITQQIIPVLYCMVFIAGILLNGVSGWIFFYVPSSKSFIIYLKNIVIADFVMSLTFPFKILGDSGLGPWQLNVFVCRVSAVLFYVNMYVSIVFFGLISFDRYYKIVKPLW TSFIQSVSYSKLLSVIVWMLMLLLAVPNIILTNQSVREVTQIKCIELKSELGRKWHKASNYIFVAIFWIVFLLLIVFYTAITKKIFKSHLKSSRNSTSVKKKSSRNIFSIVFVFFVCFVPYHIARIPY TKSQTEAHYSCQSKEILRYMKEFTLLLSAANVCLDPIIYFFLCQPFREILCKKLHIPLKAQNDLDISRIKRGNTTLESTDTL hide sequence

Protein Domains

G-protein coupled receptors family 1 profile

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q15391-F1-model_v2	AlphaFold	Q15391	1-338	view protein structure

RGD ID:

Promoter ID:

Type:

initiation region

Name:

P2RY14_2

Description:

purinergic receptor P2Y14

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H6172

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	151,278,366 - 151,278,426	EPDNEW

RGD ID:

Promoter ID:

Type:

initiation region

Name:

P2RY14_1

Description:

purinergic receptor P2Y14

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H6171

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	151,278,542 - 151,278,602	EPDNEW

Database	Acc Id	Source(s)
COSMIC	P2RY14	COSMIC
Ensembl Genes	ENSG00000174944	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000309170	ENTREZGENE
	ENST00000309170.8	UniProtKB/Swiss-Prot
	ENST00000424796	ENTREZGENE
	ENST00000424796.6	UniProtKB/Swiss-Prot
Gene3D-CATH	Rhodopsin 7-helix transmembrane proteins	UniProtKB/Swiss-Prot
GTEx	ENSG00000174944	GTEx
HGNC ID	HGNC:16442	ENTREZGENE
Human Proteome Map	P2RY14	Human Proteome Map
InterPro	GPCR_Rhodpsn	UniProtKB/Swiss-Prot
	GPCR_Rhodpsn_7TM	UniProtKB/Swiss-Prot
	P2Y14_rcpt	UniProtKB/Swiss-Prot
KEGG Report	hsa:9934	UniProtKB/Swiss-Prot
NCBI Gene	9934	ENTREZGENE
OMIM	610116	OMIM
PANTHER	P2Y PURINOCEPTOR 14	UniProtKB/Swiss-Prot
	P2Y PURINOCEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR	UniProtKB/Swiss-Prot
Pfam	7tm_1	UniProtKB/Swiss-Prot
PharmGKB	PA28853	PharmGKB
PRINTS	GPCRRHODOPSN	UniProtKB/Swiss-Prot
	P2YPURNOCPTR	UniProtKB/Swiss-Prot
	UDPGLUCOSER	UniProtKB/Swiss-Prot
PROSITE	G_PROTEIN_RECEP_F1_2	UniProtKB/Swiss-Prot
Superfamily-SCOP	Family A G protein-coupled receptor-like	UniProtKB/Swiss-Prot
UniProt	A5JUU3	ENTREZGENE, UniProtKB/TrEMBL
	C9JAB5_HUMAN	UniProtKB/TrEMBL
	P2Y14_HUMAN	UniProtKB/Swiss-Prot, ENTREZGENE
	Q8IYT7	ENTREZGENE
UniProt Secondary	Q8IYT7	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2016-02-10	P2RY14	purinergic receptor P2Y14	P2RY14	purinergic receptor P2Y, G-protein coupled, 14	Symbol and/or name change	5135510	APPROVED